Correlation Between Beta Drugs and Max Healthcare

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Max Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Max Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and Max Healthcare Institute, you can compare the effects of market volatilities on Beta Drugs and Max Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Max Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Max Healthcare.

Diversification Opportunities for Beta Drugs and Max Healthcare

0.88

Correlation Coefficient

Beta Drugs  Max Healthcare

Very poor diversification

The 3 months correlation between Beta and Max is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Max Healthcare Institute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Max Healthcare Institute and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Max Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Max Healthcare Institute has no effect on the direction of Beta Drugs i.e., Beta Drugs and Max Healthcare go up and down completely randomly.

Pair Corralation between Beta Drugs and Max Healthcare

Assuming the 90 days trading horizon Beta Drugs is expected to generate 33.32 times less return on investment than Max Healthcare. In addition to that, Beta Drugs is 1.38 times more volatile than Max Healthcare Institute. It trades about 0.0 of its total potential returns per unit of risk. Max Healthcare Institute is currently generating about 0.03 per unit of volatility. If you would invest  114,110  in Max Healthcare Institute on December 22, 2024 and sell it today you would earn a total of  2,915  from holding Max Healthcare Institute or generate 2.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Beta Drugs  vs.  Max Healthcare Institute

Beta Drugs

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Beta Drugs is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Max Healthcare Institute

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Max Healthcare Institute are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent essential indicators, Max Healthcare is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Beta Drugs and Max Healthcare

The main advantage of trading using opposite Beta Drugs and Max Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Max Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Max Healthcare will offset losses from the drop in Max Healthcare's long position.

The idea behind Beta Drugs and Max Healthcare Institute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.